Compare RCAT & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCAT | SDGR |
|---|---|---|
| Founded | 2002 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2017 | 2020 |
| Metric | RCAT | SDGR |
|---|---|---|
| Price | $8.94 | $18.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $20.00 | ★ $21.00 |
| AVG Volume (30 Days) | ★ 9.2M | 1.1M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.14 |
| EPS | ★ N/A | N/A |
| Revenue | $17,836,382.00 | ★ $255,869,000.00 |
| Revenue This Year | $271.60 | $0.76 |
| Revenue Next Year | $41.21 | $4.60 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 79.95 | 23.29 |
| 52 Week Low | $5.77 | $10.95 |
| 52 Week High | $18.78 | $23.02 |
| Indicator | RCAT | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 45.24 | 62.09 |
| Support Level | $8.61 | $17.23 |
| Resistance Level | $9.25 | $19.42 |
| Average True Range (ATR) | 0.80 | 0.91 |
| MACD | -0.01 | 0.16 |
| Stochastic Oscillator | 18.08 | 68.75 |
Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Its suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities. The firm's Division includes Teal, FlightWave, and Blue Ops.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.